These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Prospective, randomized, double-blind, placebo-controlled trial of ulinastatin for prevention of hyperenzymemia after double balloon endoscopy via the antegrade approach. Itaba S, Nakamura K, Aso A, Tokunaga S, Akiho H, Ihara E, Iboshi Y, Iwasa T, Akahoshi K, Ito T, Takayanagi R. Dig Endosc; 2013 Jul; 25(4):421-7. PubMed ID: 23368820 [Abstract] [Full Text] [Related]
11. Post-procedure elevated amylase and lipase levels after double-balloon enteroscopy: relations with the double-balloon technique. Pata C, Akyüz U, Erzin Y, Mutlu N, Mercan A, Dirican A. Dig Dis Sci; 2010 Jul; 55(7):1982-8. PubMed ID: 19731024 [Abstract] [Full Text] [Related]
12. Hyperamylasemia and pancreatitis following spiral enteroscopy. Teshima CW, Aktas H, Kuipers EJ, Mensink PB. Can J Gastroenterol; 2012 Sep; 26(9):603-6. PubMed ID: 22993730 [Abstract] [Full Text] [Related]
14. Is endoscopic balloon dilation for removal of bile duct stones associated with an increased risk for pancreatitis or a higher rate of hyperamylasemia? Bergman JJ, van Berkel AM, Bruno MJ, Fockens P, Rauws EA, Tijssen JG, Tytgat GN, Huibregtse K. Endoscopy; 2001 May; 33(5):416-20. PubMed ID: 11396759 [Abstract] [Full Text] [Related]
15. Factors affecting pancreatic hyperamylasemia in patients undergoing peroral single-balloon enteroscopy. Tsujikawa T, Bamba S, Inatomi O, Hasegawa H, Ban H, Nishida A, Imaeda H, Itoh A, Saotome T, Sasaki M, Andoh A. Dig Endosc; 2015 Sep; 27(6):674-8. PubMed ID: 25630832 [Abstract] [Full Text] [Related]
18. Complications in and performance of double-balloon enteroscopy (DBE): results from a large prospective DBE database in Germany. Möschler O, May A, Müller MK, Ell C, German DBE Study Group. Endoscopy; 2011 Jun; 43(6):484-9. PubMed ID: 21370220 [Abstract] [Full Text] [Related]
19. [Early postoperative hyperamylasemia after parathyroidectomy for primary hyperparathyroidism]. Solis-Caxaj CA, Jafari M, Latteux C, Galleri D, Pattou F, Carnaille B, Franceschi A, Proye C. Ann Chir; 2004 Jun; 129(5):269-72. PubMed ID: 15220099 [Abstract] [Full Text] [Related]